National Health Investors (NHI) is a publicly traded Real Estate sector company. As of July 27, 2026, NHI trades at $80.54 with a market cap of $3.90B and a P/E ratio of 25.90. NHI moved +0.74% today. Year to date, NHI is +3.82%; over the trailing twelve months it is +13.21%. Its 52-week range spans $65.13 to $91.38. Analyst consensus is buy with an average price target of $84.20. Rallies surfaces NHI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest NHI news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $80.54 |
| Market Cap | $3.90B |
| P/E Ratio | 25.90 |
| EPS | $3.11 |
| Dividend Yield | 0.92% |
| 52-Week High | $91.38 |
| 52-Week Low | $65.13 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $401.46M |
| Net Income | $146.72M |
| Gross Margin | 0.00% |
5 analysts cover NHI: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $84.20.